Optimization of Cytostatic Leukemia Therapy in an Advection–Reaction–Diffusion Model

In this work, we study an advection–reaction–diffusion system involving normal and cancer hematopoietic cells (HC) and modeling the development of leukemia in the bone marrow. The effects of a targeted cytostatic therapy, which inhibits the regeneration of cancer HC, are studied through an optimal control system. We prove the existence of a positive bounded solution and the existence of an optimal controls by semigroup techniques. Conditions of optimality are in terms of the dual system. The effects of targeted cytostatic therapy, upon the dynamics of normal and cancer HC, are discussed through numerical simulations.

[1]  Malin Prenkert,et al.  On mechanisms of drug resistance in acute myeloid leukemia , 2010 .

[2]  Herbert Amann,et al.  Linear and Quasilinear Parabolic Problems: Volume I: Abstract Linear Theory , 1995 .

[3]  Arnaud Ducrot,et al.  On a Model of Leukemia Development with a Spatial Cell Distribution , 2007 .

[4]  Mark A. J. Chaplain,et al.  Mathematical modeling of cancer cell invasion of tissue: biological insight from mathematical analysis and computational simulation , 2011, Journal of mathematical biology.

[5]  Hieber Matthias,et al.  Heat kernels and maximal lp—lqestimates for parabolic evolution equations , 1997 .

[6]  Ricardo Ruiz-Baier,et al.  Analysis of an optimal control problem for the tridomain model in cardiac electrophysiology , 2012 .

[7]  A. Prokop,et al.  Modeling the Cancer Stem Cell Hypothesis , 2010 .

[8]  Kang Li,et al.  NOTCH1 Signaling Promotes Human T-Cell Acute Lymphoblastic Leukemia Initiating Cell Regeneration in Supportive Niches , 2012, PloS one.

[9]  V. Volpert,et al.  Reaction-diffusion waves in biology. , 2009, Physics of life reviews.

[10]  I. Weissman,et al.  Stem cells, cancer, and cancer stem cells , 2001, Nature.

[11]  Chahrazed Benosman,et al.  Global dynamics of hematopoietic stem cells and differentiated cells in a chronic myeloid leukemia model , 2011, Journal of mathematical biology.

[12]  A. Ferrando,et al.  Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. , 2011, Blood reviews.

[13]  T. Mughal,et al.  Principal long-term adverse effects of imatinib in patients with chronic myeloid leukemia in chronic phase , 2010, Biologics : targets & therapy.

[14]  Elena Fimmel,et al.  On optimal and suboptimal treatment strategies for a mathematical model of leukemia. , 2012, Mathematical biosciences and engineering : MBE.

[15]  Scott A Armstrong,et al.  Leukemia stem cells and human acute lymphoblastic leukemia. , 2009, Seminars in hematology.

[16]  Herbert Amann,et al.  Linear and Quasilinear Parabolic Problems , 2019, Monographs in Mathematics.

[17]  E. Steliarova-Foucher,et al.  Skin cancer incidence and survival in European children and adolescents (1978-1997). Report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.

[18]  Scott V. Edwards,et al.  Sex Chromosome Evolution in Amniotes: Applications for Bacterial Artificial Chromosome Libraries , 2010, Journal of biomedicine & biotechnology.

[19]  Bedr'Eddine Ainseba,et al.  Optimal control problem on insect pest populations , 2011, Appl. Math. Lett..

[20]  Eduardo Marbán,et al.  Brief Report: Mechanism of Extravasation of Infused Stem Cells , 2012, Stem cells.

[21]  Denis Wirtz,et al.  The physics of cancer: the role of physical interactions and mechanical forces in metastasis , 2011, Nature Reviews Cancer.

[22]  J. Prüss.  Evolutionary Integral Equations And Applications , 1993 .

[23]  Hua Zhou,et al.  Extinction models for cancer stem cell therapy. , 2011, Mathematical biosciences.

[24]  Håkon Reikvam,et al.  Acute Myeloid Leukemia with the t(8;21) Translocation: Clinical Consequences and Biological Implications , 2011, Journal of biomedicine & biotechnology.

[25]  Ombretta Annibali,et al.  Cytogenetic abnormalities in adult non-promyelocytic acute myeloid leukemia: a concise review. , 2011, Critical reviews in oncology/hematology.

[26]  Marshall A Lichtman,et al.  Familial (inherited) leukemia, lymphoma, and myeloma: an overview. , 2004, Blood cells, molecules & diseases.

[27]  Duc Cuong Pham,et al.  Effect of Health Expenses on Household Capabilities and Resource Allocation in a Rural Commune in Vietnam , 2012, PloS one.

[28]  R. Stone,et al.  Targeted agents in AML: much more to do. , 2007, Best practice & research. Clinical haematology.

[29]  Urszula Ledzewicz,et al.  Mathematical methods and models in biomedicine , 2013 .

[30]  Natalia L. Komarova,et al.  Stem Cell Control, Oscillations, and Tissue Regeneration in Spatial and Non-Spatial Models , 2013, Frontiers in Oncology.

[31]  Amnon Pazy,et al.  Semigroups of Linear Operators and Applications to Partial Differential Equations , 1992, Applied Mathematical Sciences.

[32]  Arnaud Ducrot,et al.  spatial distribution of cell populations in the process of erythropoiesis , 2010 .

[33]  Pierre Fenaux,et al.  A phase 2 study of the oral farnesyltransferase inhibitor tipifarnib in patients with refractory or relapsed acute myeloid leukemia. , 2007, Blood.

[34]  Sigrid Stroobants,et al.  Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group. , 2002, European journal of cancer.

[35]  H. Greenspan.  Models for the Growth of a Solid Tumor by Diffusion , 1972 .

[36]  E. López-Bayghen,et al.  Cell Proliferation, Differentiation and Apoptosis , 2012 .

[37]  E. Steliarova-Foucher,et al.  Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997. Report from the Automated Childhood Cancer Information System project. , 2006, European journal of cancer.

[38]  R. Bast,et al.  Holland-Frei Cancer Medicine , 2016 .

[39]  Stanley He,et al.  MYCN and the epigenome , 2013, Front. Oncol..

[40]  Maria Neuss-Radu,et al.  Derivation and analysis of a system modeling the chemotactic movement of hematopoietic stem cells , 2008, Journal of mathematical biology.

[41]  S. Lyle,et al.  Quiescent, Slow-Cycling Stem Cell Populations in Cancer: A Review of the Evidence and Discussion of Significance , 2010, Journal of oncology.

[42]  J. M. Ball,et al.  GEOMETRIC THEORY OF SEMILINEAR PARABOLIC EQUATIONS (Lecture Notes in Mathematics, 840) , 1982 .

[43]  Atsushi Hirao,et al.  Ablation of Fbxw7 eliminates leukemia-initiating cells by preventing quiescence. , 2013, Cancer cell.

[44]  S. Iwata,et al.  CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells. , 2009, Biochemical and biophysical research communications.

[45]  Angela Ferrari,et al.  Severe skin reaction in a patient with gastrointestinal stromal tumor treated with imatinib mesylate. , 2006, Anticancer research.

[46]  Kamonnaree Chotinantakul,et al.  Hematopoietic Stem Cell Development, Niches, and Signaling Pathways , 2012, Bone marrow research.

[47]  Mimmo Iannelli,et al.  Optimal Control of Population Dynamics , 1999 .

[48]  D. Gilliland,et al.  Leukemia stem cells. , 2010, Seminars in cancer biology.

[49]  Shahragim Tajbakhsh,et al.  Stem cell: what's in a name? , 2009 .

[50]  Lina Souan,et al.  Imatinib mesylate inhibits T-cell proliferation in vitro and delayed-type hypersensitivity in vivo. , 2004, Blood.

[51]  John Carl Panetta,et al.  Optimal Control Applied to Cell-Cycle-Specific Cancer Chemotherapy , 2000, SIAM J. Appl. Math..

[52]  F. Michor,et al.  Mathematical models of targeted cancer therapy , 2006, British Journal of Cancer.

[53]  K. Antman,et al.  Imatinib mesylate--a new oral targeted therapy. , 2002, The New England journal of medicine.

[54]  F. Xiao.  Drug therapy , 2016 .

[55]  Daniel B. Henry.  Geometric Theory of Semilinear Parabolic Equations , 1989 .

[56]  Jean Clairambault,et al.  Modelling Physiological and Pharmacological Control on Cell Proliferation to Optimise Cancer Treatments , 2009 .